Concepedia

Author

J.M. Holzbeierlein

University of Kansas Medical Center

Also Known As

J. Holzbeierlein, J. M. Holzbeierlein, J.M. Holzbeierlein, Jeffery Holzbeierlein, Jeffery M. Holzbeierlein

16

Publications

485

Citations

8

H-Index

27

Concepts

All Affiliations

University of Kansas Medical CenterUniversity of Kansas
JH

About

J.M. Holzbeierlein is an author at University of Kansas Medical Center specializing in medicine, urology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

241

2

Cell Biology

2

2

199

3

Immunology

2

2

42

4

Health Sciences

1

1

21

5

Cancer Metabolism

1

1

83

J.M. Holzbeierlein

×

6

Publications

454

Citations

6

H-Index

YearCitations

Androgen Stimulates Matrix Metalloproteinase-2 Expression in Human Prostate Cancer

Xinbo Liao, J. Brantley Thrasher, Jill C. Pelling,

Endocrinology

2003

116

Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor

Anuj Khandelwal, Caitlin N. Kent, Maurie Balch,

Nature Communications

2018

114

Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo

Qing Zhu, Jun Yang, Suxia Han,

The Prostate

2010

99

Glycogen Synthase Kinase-3β Activity Is Required for Androgen-Stimulated Gene Expression in Prostate Cancer

Xinbo Liao, J. Brantley Thrasher, J.M. Holzbeierlein,

Endocrinology

2004

83

A phase II study testing the safety and activity of AGS-003 as an immunotherapeutic in subjects with newly diagnosed advanced stage renal cell carcinoma (RCC) in combination with sunitinib.

A.M. Amin, Alexandra Dudek, Theodore F. Logan,

Journal of Clinical Oncology

2010

21

Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.

Robert A. Figlin, Charles A. Nicolette, Alpesh Amin,

Journal of Clinical Oncology

2011

21

Page 1